COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03393845
Brief Title: Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients

First Submitted : January 2, 2018
First Submitted that Met QC Criteria : January 3, 2018
First Posted : January 9, 2018

Last Update Submitted that Met QC Criteria : February 14, 2019
Last Update Posted : February 15, 2019